Photo-activation therapy with high-Z nanoparticles: modelling at a micrometer level and experimental comparison - Archive ouverte HAL Access content directly
Conference Papers Year : 2012

Photo-activation therapy with high-Z nanoparticles: modelling at a micrometer level and experimental comparison

(1) , (1) , (2) , (3) , (3) , (3) , (4)
1
2
3
4

Abstract

An innovative approach using X-rays interactions with heavy elements seems to open a promising way of treatment for resistant cancers, such as high-grade gliomas. The use of gold nanoparticles to treat mice bearing subcutaneous tumors led to encouraging results [3]. However, the physical processes and biological impact of the photon activation of nanoparticles are not well understood. The aim of this study was to evaluate, at the cellular level, the dose enhancement in presence of nanoparticles and the properties of the secondary electrons production using the Monte Carlo transport code PENELOPE. At first, upstream studies were done around the behavior of gadolinium and gold nanoparticles (GdNP and AuNP) under irradiation. Then dose calculations were done in a cellular geometry containing gadolinium-water mixture in order to compare with experimentations realized on the ID17 beamline of ESRF.
Fichier principal
Vignette du fichier
article_RachelDelorme_GordonResearchSeminar 2012.pdf (351.25 Ko) Télécharger le fichier
Vignette du fichier
presentation_RachelDelorme_GordonResearchSeminar2012.pdf (1.41 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

cea-02626577 , version 1 (28-05-2020)

Identifiers

  • HAL Id : cea-02626577 , version 1

Cite

R. Delorme, Mathieu Agelou, Christophe Champion, Hélène Elleaume, Florence Taupin, et al.. Photo-activation therapy with high-Z nanoparticles: modelling at a micrometer level and experimental comparison. Gordon Research Seminar on Radiation Chemistry 2012, William A. Bernhard; Jay A. Laverne, Jul 2012, Andover, United States. ⟨cea-02626577⟩
52 View
22 Download

Share

Gmail Facebook Twitter LinkedIn More